Orphan designation: doruxapapogene ralaplasmid Treatment of recurrent respiratory papillomatosis, 22/05/2023 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 January 2024 - 14:03

Orphan designation: doruxapapogene ralaplasmid Treatment of recurrent respiratory papillomatosis, 22/05/2023 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-23-2785

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters